Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 165679, 7 pages
http://dx.doi.org/10.1155/2015/165679
Research Article

Protective Effects of Total Saponins of Panax Notoginseng on Steroid-Induced Avascular Necrosis of the Femoral Head In Vivo and In Vitro

Department of Orthopedics, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received 7 November 2014; Revised 12 January 2015; Accepted 13 January 2015

Academic Editor: Shuang-En Chuang

Copyright © 2015 Heng-feng Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Assouline-Dayan, C. Chang, A. Greenspan, Y. Shoenfeld, and M. E. Gershwin, “Pathogenesis and natural history of osteonecrosis,” Seminars in Arthritis and Rheumatism, vol. 32, no. 2, pp. 94–124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Hernigou, A. Poignard, A. Nogier, and O. Manicom, “Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip,” Journal of Bone and Joint Surgery—Series A, vol. 86, no. 12, pp. 2589–2593, 2004. View at Google Scholar · View at Scopus
  3. R. S. Weinstein, R. W. Nicholas, and S. C. Manolagas, “Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 8, pp. 2907–2912, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-S. Youm, S.-Y. Lee, and S.-H. Lee, “Apoptosis in the osteonecrosis of the femoral head,” Clinics in Orthopedic Surgery, vol. 2, no. 4, pp. 250–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. S. Zheng, S. F. Schlosser, T. Dao et al., “Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13618–13623, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Yao, P. Shi, Q. Shao, and X. Fan, “Chemical fingerprinting and quantitative analysis of a Panax notoginseng preparation using HPLC-UV and HPLC-MS,” Chinese Medicine, vol. 6, article 9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. W. Chen, X. H. Li, K. H. Ye, Z. F. Jiang, and X. D. Ren, “Total saponins of Panax notoginseng protected rabbit iliac artery against balloon endothelial denudation injury,” Acta Pharmacologica Sinica, vol. 25, no. 9, pp. 1151–1156, 2004. View at Google Scholar · View at Scopus
  8. H. Zheng, C. Liu, Y. Ou, Y. Zhang, and X. Fu, “Total saponins of panax notoginseng enhance VEGF and relative receptors signals and promote angiogenesis derived from rat bone marrow mesenchymal stem cells,” Journal of Ethnopharmacology, vol. 147, no. 3, pp. 595–602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Zhou, Y. Tang, R. F. Keep, X. Ma, and J. Xiang, “Antioxidative effects of Panax notoginseng saponins in brain cells,” Phytomedicine, vol. 21, no. 10, pp. 1189–1195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Li, C.-Q. Deng, B.-Y. Chen, S.-P. Zhang, Y. Liang, and X.-G. Luo, “Total saponins of Panax Notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion,” Journal of Ethnopharmacology, vol. 121, no. 3, pp. 412–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Qiang, C. Zhang, Z.-B. Shi, H.-Q. Yang, and K.-Z. Wang, “Protective effects and mechanism of Panax Notoginseng saponins on oxidative stress-induced damage and apoptosis of rabbit bone marrow stromal cells,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 525–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Shi, G. Li, P. Wang et al., “Effect of antler extract on corticosteroid-induced avascular necrosis of the femoral head in rats,” Journal of Ethnopharmacology, vol. 127, no. 1, pp. 124–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. C. Babis, V. Sakellariou, J. Parvizi, and P. Soucacos, “Osteonecrosis of the femoral head,” Orthopedics, vol. 34, no. 1, pp. 39–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. S. Weinstein, “Glucocorticoid-induced osteonecrosis,” Endocrine, vol. 41, no. 2, pp. 183–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. G. Zalavras and J. R. Lieberman, “Osteonecrosis of the femoral head: evaluation and treatment,” Journal of the American Academy of Orthopaedic Surgeons, vol. 22, no. 7, pp. 455–464, 2014. View at Publisher · View at Google Scholar
  16. W. Drescher, T. Schneider, C. Becker et al., “Selective reduction of bone blood flow by short-term treatment with high-dose methylprednisolone. An experimental study in pigs,” Journal of Bone and Joint Surgery—Series B, vol. 83, no. 2, pp. 274–277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Fondi and A. Franchi, “Definition of bone necrosis by the pathologist,” Clinical Cases in Mineral and Bone Metabolism, vol. 4, no. 1, pp. 21–26, 2007. View at Google Scholar · View at Scopus
  18. T. Fang, E. W. Zhang, F. C. Sailes, R. A. McGuire, W. C. Lineaweaver, and F. Zhang, “Vascularized fibular grafts in patients with avascular necrosis of femoral head: a systematic review and meta-analysis,” Archives of Orthopaedic and Trauma Surgery, vol. 133, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Zalavras, S. Shah, M. J. Birnbaum, and B. Frenkel, “Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis,” Critical Reviews in Eukaryotic Gene Expression, vol. 13, no. 2–4, pp. 221–235, 2003. View at Google Scholar · View at Scopus
  20. G. Y. Rochefort and C.-L. Benhamou, “Osteocytes are not only mechanoreceptive cells,” International Journal for Numerical Methods in Biomedical Engineering, vol. 29, no. 10, pp. 1082–1088, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Y. Esmail, L. Sun, L. Yu, H. Xu, L. Shi, and J. Zhang, “Effects of PEMF and glucocorticoids on proliferation and differentiation of osteoblasts,” Electromagnetic Biology and Medicine, vol. 31, no. 4, pp. 375–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Li, W. Qian, X. Weng et al., “Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells,” PLoS ONE, vol. 7, no. 6, Article ID e37030, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Xu, H. Wen, Y. Hu et al., “STAT1-caspase 3 pathway in the apoptotic process associated with steroid-induced necrosis of the femoral head,” Journal of Molecular Histology, vol. 45, no. 4, pp. 473–485, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. C. Chua, B. H. L. Chua, Z. Chen, C. Landy, and R. C. Hamdy, “Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1642, no. 1-2, pp. 79–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Liu, A. Porta, X. Peng et al., “Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k,” Journal of Bone and Mineral Research, vol. 19, no. 3, pp. 479–490, 2004. View at Publisher · View at Google Scholar · View at Scopus